Prudential plc’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Sell |
136,470
-45,200
| -25% | -$1.1M | 0.02% | 330 |
|
|
2025
Q1 | $3.77M | Buy |
181,670
+21,300
| +13% | +$442K | 0.02% | 313 |
|
|
2024
Q4 | $3.78M | Buy |
160,370
+15,200
| +10% | +$358K | 0.02% | 289 |
|
|
2024
Q3 | $3.72M | Buy |
145,170
+5,000
| +4% | +$128K | 0.02% | 301 |
|
|
2024
Q2 | $3.33M | Buy |
140,170
+18,300
| +15% | +$434K | 0.02% | 321 |
|
|
2024
Q1 | $3.5M | Sell |
121,870
-3,900
| -3% | -$112K | 0.03% | 314 |
|
|
2023
Q4 | $4.31M | Buy |
125,770
+8,400
| +7% | +$288K | 0.04% | 269 |
|
|
2023
Q3 | $3.27M | Sell |
117,370
-6,200
| -5% | -$173K | 0.04% | 281 |
|
|
2023
Q2 | $4.17M | Sell |
123,570
-8,600
| -7% | -$290K | 0.05% | 243 |
|
|
2023
Q1 | $3.79M | Hold |
132,170
| – | – | 0.04% | 246 |
|
|
2022
Q4 | $3.73M | Sell |
132,170
-5,000
| -4% | -$141K | 0.05% | 247 |
|
|
2022
Q3 | $4.51M | Sell |
137,170
-8,700
| -6% | -$286K | 0.07% | 179 |
|
|
2022
Q2 | $4.69M | Buy |
145,870
+8,000
| +6% | +$257K | 0.09% | 163 |
|
|
2022
Q1 | $6.45M | Buy |
137,870
+6,570
| +5% | +$307K | 0.09% | 124 |
|
|
2021
Q4 | $8.17M | Buy |
131,300
+10,700
| +9% | +$665K | 0.11% | 84 |
|
|
2021
Q3 | $8.91M | Buy |
120,600
+300
| +0.2% | +$22.2K | 0.12% | 74 |
|
|
2021
Q2 | $11.1M | Buy |
120,300
+22,100
| +23% | +$2.04M | 0.1% | 133 |
|
|
2021
Q1 | $8.71M | Buy |
+98,200
| New | +$8.71M | 0.06% | 253 |
|
|
2020
Q4 | – | Sell |
-44,950
| Closed | -$2.86M | – | 608 |
|
|
2020
Q3 | $2.86M | Buy |
44,950
+16,400
| +57% | +$1.04M | 0.01% | 330 |
|
|
2020
Q2 | $1.49M | Buy |
+28,550
| New | +$1.49M | 0.01% | 365 |
|